Back to
Mariner, LLC
AXSM
Showing 8 of 15 quarters
Position history for
Mariner, LLC's holdings in Axsome Therapeutics, Inc.
Yes. Mariner holds 18,262 shares of AXSM (Axsome Therapeutics), worth $4.5M, as of its Q2 2026 13F filing. It increased the position by 1,448 shares (+8.6%) from Q1 2026. Mariner has held AXSM since Q4 2023, across 11 quarterly 13F filings.
Current Value
$4.5M
Current Shares
18,262
Total Value Change
+$3.3M
Total Shares Change
+4,976
Quarter-by-Quarter History